These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 15880572)

  • 1. Doxorubicin induces expression of multidrug resistance-associated protein 1 in human small cell lung cancer cell lines by the c-jun N-terminal kinase pathway.
    Shinoda C; Maruyama M; Fujishita T; Dohkan J; Oda H; Shinoda K; Yamada T; Miyabayashi K; Hayashi R; Kawagishi Y; Fujita T; Matsui S; Sugiyama E; Muraguchi A; Kobayashi M
    Int J Cancer; 2005 Oct; 117(1):21-31. PubMed ID: 15880572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of the efficacy of chemotherapy for lung cancer by simultaneous suppression of multidrug resistance and antiapoptotic cellular defense: novel multicomponent delivery system.
    Pakunlu RI; Wang Y; Tsao W; Pozharov V; Cook TJ; Minko T
    Cancer Res; 2004 Sep; 64(17):6214-24. PubMed ID: 15342407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of amiodarone, cyclosporin A, and PSC 833 on the cytotoxicity of mitoxantrone, doxorubicin, and vincristine in non-P-glycoprotein human small cell lung cancer cell lines.
    van der Graaf WT; de Vries EG; Timmer-Bosscha H; Meersma GJ; Mesander G; Vellenga E; Mulder NH
    Cancer Res; 1994 Oct; 54(20):5368-73. PubMed ID: 7923167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Modulation of human small cell lung cancer cell line GLC4/ADR multidrug resistance in the inhibition of multidrug resistance-associated protein and its antisense].
    Peng X; Feng F; Zhang W
    Zhonghua Zhong Liu Za Zhi; 2001 Sep; 23(5):355-8. PubMed ID: 11810759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of broad drug resistance in small cell lung cancer cells and its reversal by paclitaxel.
    Su GM; Davey MW; Davey RA
    Int J Cancer; 1998 May; 76(5):702-8. PubMed ID: 9610729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multidrug resistance proteins MRP3, MRP1, and MRP2 in lung cancer: correlation of protein levels with drug response and messenger RNA levels.
    Young LC; Campling BG; Cole SP; Deeley RG; Gerlach JH
    Clin Cancer Res; 2001 Jun; 7(6):1798-804. PubMed ID: 11410522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxia can impair doxorubicin resistance of non-small cell lung cancer cells by inhibiting MRP1 and P-gp expression and boosting the chemosensitizing effects of MRP1 and P-gp blockers.
    Chen YL; Yang TY; Chen KC; Wu CL; Hsu SL; Hsueh CM
    Cell Oncol (Dordr); 2016 Oct; 39(5):411-433. PubMed ID: 27306525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. JNK1, JNK2, and JNK3 are involved in P-glycoprotein-mediated multidrug resistance of hepatocellular carcinoma cells.
    Yan F; Wang XM; Liu ZC; Pan C; Yuan SB; Ma QM
    Hepatobiliary Pancreat Dis Int; 2010 Jun; 9(3):287-95. PubMed ID: 20525557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upregulation of the inwardly rectifying potassium channel Kir2.1 (KCNJ2) modulates multidrug resistance of small-cell lung cancer under the regulation of miR-7 and the Ras/MAPK pathway.
    Liu H; Huang J; Peng J; Wu X; Zhang Y; Zhu W; Guo L
    Mol Cancer; 2015 Mar; 14():59. PubMed ID: 25880778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 6-(7-Nitro-2,1,3-benzoxadiazol-4-ylthio)hexanol, a specific glutathione S-transferase inhibitor, overcomes the multidrug resistance (MDR)-associated protein 1-mediated MDR in small cell lung cancer.
    Filomeni G; Turella P; Dupuis ML; Forini O; Ciriolo MR; Cianfriglia M; Pezzola S; Federici G; Caccuri AM
    Mol Cancer Ther; 2008 Feb; 7(2):371-9. PubMed ID: 18281520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A dominant role for the c-Jun NH2-terminal kinase in oncogenic ras-induced morphologic transformation of human lung carcinoma cells.
    Xiao L; Lang W
    Cancer Res; 2000 Jan; 60(2):400-8. PubMed ID: 10667594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disulfiram/copper complex activated JNK/c-jun pathway and sensitized cytotoxicity of doxorubicin in doxorubicin resistant leukemia HL60 cells.
    Xu B; Shi P; Fombon IS; Zhang Y; Huang F; Wang W; Zhou S
    Blood Cells Mol Dis; 2011 Dec; 47(4):264-9. PubMed ID: 21911303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vielanin P enhances the cytotoxicity of doxorubicin via the inhibition of PI3K/Nrf2-stimulated MRP1 expression in MCF-7 and K562 DOX-resistant cell lines.
    Gao HL; Xia YZ; Zhang YL; Yang L; Kong LY
    Phytomedicine; 2019 May; 58():152885. PubMed ID: 31009836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Signal transduction pathways in Burkitt's lymphoma cell lines BL41 and DG75 with different sensitivity to doxorubicin.
    Shlapatska LM; Berdova GG; Kovalevska LM; Kulyk GI; Klein G; Sidorenko SP; Chekhun VF
    Exp Oncol; 2004 Sep; 26(3):210-6. PubMed ID: 15494689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-1beta induces MMP-9 expression via a Ca2+-dependent CaMKII/JNK/c-JUN cascade in rat brain astrocytes.
    Wu CY; Hsieh HL; Sun CC; Yang CM
    Glia; 2009 Dec; 57(16):1775-89. PubMed ID: 19455716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulation of Multidrug Resistance-Associated Protein 1 by Allyl Isothiocyanate in Human Bronchial Epithelial Cell: Involvement of c-Jun N-Terminal Kinase Signaling Pathway.
    Wang S; Wang S; Wang C; Chen Y; Li J; Wang X; Wang D; Li Z; Peng Z; Fan L
    Oxid Med Cell Longev; 2015; 2015():903782. PubMed ID: 26273426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determinants of differential doxorubicin sensitivity between SCLC and NSCLC.
    Singhal SS; Wickramarachchi D; Singhal J; Yadav S; Awasthi YC; Awasthi S
    FEBS Lett; 2006 Apr; 580(9):2258-64. PubMed ID: 16579994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Iron N-(2-hydroxy acetophenone) glycinate (FeNG), a non-toxic glutathione depletor circumvents doxorubicin resistance in Ehrlich ascites carcinoma cells in vivo.
    Ganguly A; Chakraborty P; Banerjee K; Chatterjee S; Basu S; Sarkar A; Chatterjee M; Choudhuri SK
    Biometals; 2012 Feb; 25(1):149-63. PubMed ID: 21915630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. c-Jun N-terminal kinase is activated in non-small-cell lung cancer and promotes neoplastic transformation in human bronchial epithelial cells.
    Khatlani TS; Wislez M; Sun M; Srinivas H; Iwanaga K; Ma L; Hanna AE; Liu D; Girard L; Kim YH; Pollack JR; Minna JD; Wistuba II; Kurie JM
    Oncogene; 2007 Apr; 26(18):2658-66. PubMed ID: 17057737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-acetylcysteine enhances multidrug resistance-associated protein 1 mediated doxorubicin resistance.
    Akan I; Akan S; Akca H; Savas B; Ozben T
    Eur J Clin Invest; 2004 Oct; 34(10):683-9. PubMed ID: 15473893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.